Aberrant expression of histo-blood group a type 3 antigens in vascular endothelial cells in inflammatory sites

Journal of Histochemistry and Cytochemistry

Volumn 56, Issue 3, 2008, Pages 223-231

  Nosaka, Mizuho ^a   Ishida, Yuko ^a   Tanaka, Aki ^a   Hayashi, Takahito ^a   Miyashita, Tomoko ^a   Kaminaka, Chikako ^a   Eisenmenger, Wolfgang ^b   Furukawa, Fukumi ^a   Kimura, Akihiko ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Histo blood group A type 3 antigen; Inflammation; Vascular endothelial cell; Von Willebrand factor; Wound healing

Indexed keywords

BLOOD GROUP A ANTIGEN; VON WILLEBRAND FACTOR;

ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP A; BLOOD GROUP AB; ENDOTHELIUM CELL; HUMAN; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SKIN CULTURE; SKIN INFLAMMATION; SKIN INJURY; SWEAT GLAND; VASCULAR ENDOTHELIUM;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; AGED, 80 AND OVER; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MIDDLE AGED; SKIN; SKIN DISEASES; VON WILLEBRAND FACTOR;

EID: 39449089349     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.7A7290.2007     Document Type: Article

References (49)

1. Adobati E, Panza L, Russo G, Colnaghi MI, Canevari S (1997) In vitro mimicry of CaMBr1 tumor-associated antigen by synthetic oligosaccharides. Glycobiology 7:173-178
2. Bernardo A, Ball C, Nolasco L, Moake JF, Dong JF (2004) Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood 104:100-106
3. Bonifati C, Carducci M, Mussi A, D'auria L, Ameglio F (1997) IL-1α, IL-1β and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin. J Biol Regul Homeost Agents 11:133-136
4. Bowen DJ (2003) An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost 1:33-40
5. Bremer EG, Levery SB, Sonnino S, Ghidoni R, Canevari S, Kannagi R, Hakomori S (1984) Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. J Biol Chem 259:14773-14777
6. Brown SA, Collins PW, Bowen DJ (2002) Heterogeneous detection of A-antigen on von Willebrand factor derived from platelets, endothelial cells and plasma. Thromb Haemost 87:990-996
7. Bryne M, Lilleholt S, Thrane PS, Koppang HS, Dabelsteen E (1993) Distribution of blood-group-related carbohydrate antigens on oral endothelial cells. Histochem J 25:339-347
8. Chang CH, Hang Y, Issekutz AC, Griffith M, Lin KH, Anderson R (2002) Interleukin-1α released from epithelial cells after adenovirus type 37 infection activates intercellular adhesion molecule 1 expression on human vescular endothelial cells. J Virol 76:427-431
9. Clausen H, Hakomori S (1989) ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang 56:1-20
10. 2 enzymes, and type 3 chain H expression in relation to secretor status. J Biol Chem 261:1388-1392
11. Clausen H, Levery SB, Kannagi R, Hakomori S (1986b) Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H). I. Isolation and chemical characterization. J Biol Chem 261:1380-1387
12. Clausen H, Levery SB, Nudelman ED, Stroud M, Salyan ME, Hakomori S (1987) Isolation and characterization of novel glycolipids with blood group A-related structures: galactosyl-A and sialosylgalactosyl-A. J Biol Chem 262:14228-14234
13. Clausen H, Levery SB, Nudelman E, Tsuchiya S, Hakomori S (1985) Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction. Proc Natl Acad Sci USA 82:1199-1203
14. Conlon PJ, Henney CS, Gillis S (1982) Cytokine-dependent thymocyte responses: characterization of IL 1 and IL 2 target subpopulations and mechanism of action. J Immunol 128:797-801
15. Cooper HS, Malecha MJ, Bass C, Fagel PL, Steplewski Z (1991) Expression of blood group antigens H-2, Le(y), and sialylated-Le(a) in human colorectal carcinoma. An immunohistochemical study using double-labeling techniques. Am J Pathol 138:103-110
16. Cumberbatch M, Dearman RJ, Groves RW, Antonopoulos C, Kimber I (2002) Differential regulation of epidermal langerhans cell migration by interleukins (IL)-1α and IL-1β during irritant-and allergen-induced cutaneous immune responses. Toxicol Appl Pharmacol 182:126-135
17. Dabelsteen E, Broby-Johansen U, Jeppe-Jensen D, Mandel U (1990) Cell surface glycosylation patterns in psoriasis. APMIS 98:221-228
18. Dabelsteen E, Gao S (2005) ABO blood-group antigens in oral cancer. J Dent Res 84:21-28
19. Dabelsteen E, Gron B, Mandel U, Mackenzie I (1998) Altered expression of epithelial cell surface glycoconjugates and intermediate filaments at the margins of mucosal wounds. J Invest Dermatol 111:592-597
20. Debets R, Hegmans JP, Croughs P, Troost RJ, Prins JB, Benner R, Prens EP (1997) The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol 158:2955-2963
21. 2 blood-group-specific glycoproteins. Eur J Biochem 120:243-249
22. Gahring LC, Buckley A, Daynes RA (1985) Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum. J Clin Invest 76:1585-1591
23. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69:1691-1695
24. Grellner W (2002) Time-dependent immunohistochemical detection of proinflammatory cytokines (IL-1β, IL-6, TNF-α) in human skin wounds. Forensic Sci Int 130:90-96
25. Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ, Woods JM, et al. (2000) Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol 164:4868-4877
26. Hauser C, Saurat JH, Schmitt A, Jaunin F, Dayer JM (1986) Interleukin 1 is present in normal human epidermis. J Immunol 136:3317-3321
27. Hayashi T, Ishida Y, Kimura A, Takayasu T, Eisenmenger W, Kondo T (2004) Forensic application of VEGF expression to skin wound age determination. Int J Legal Med 118:320-325
28. Ishida Y, Kondo T, Tsuneyama K, Lu P, Takayasu T, Mukaida N (2004) The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice. J Leukoc Biol 75:59-67
29. Jenkins PV, O'Donnell JS (2006) ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 46:1836-1844
30. Koch AE, Nickoloff BJ, Holgersson J, Seed B, Haines GK, Burrows JC, Leibovich SJ (1994) 4A11, a monoclonal antibody recognizing a novel antigen expressed on aberrant vascular endothelium. Upregulation in an in vivo model of contact dermatitis. Am J Pathol 144:244-259
31. Kondo T, Ohshima T, Eisenmenger W (1999) Immunohistochemical and morphometrical study on the temporal expression of inrerleukin-1α (IL-1α) in human skin wounds for forensic wound age determination. Int J Legal Med 112:249-252
32. Liu Y, Fujitani N, Koda Y, Soejima M, Kimura H (1999) Presence of H type 3/4 chains of ABO histo-blood group system in serous cells of human submandibular gland and regulation of their expression by the secretor gene (FUT2). J Histochem Cytochem 47:889-894
33. Macartney JC (1986) Lectin histochemistry of galactose and N-acetyl-galactosamine glycoconjugates in normal gastric mucosa and gastric cancer and the relationship with ABO and secretor status. J Pathol 150:135-144
34. Mandel U, Petersen OW, Sørensen H, Vedtofte P, Hakomori S, Clausen H, Dabelsteen E (1991) Simple mucin-type carbohydrates in oral stratified squamous and salivary gland epithelia. J Invest Dermatol 97:713-721
35. Matsui T, Shimoyama T, Matsumoto M, Fujimura Y, Takemoto Y, Sako M, Hamako J, et al. (1999) ABO blood group antigens on human plasma von Willebrand factor after ABO-mismatched bone marrow transplantation. Blood 94:2895-2900
36. Matsui T, Titani K, Mizuochi T (1992) Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem 267:8723-8731
37. Matsunaga T, Katayama I, Yokozeki H, Nishioka K (1998) Epidermal cytokine mRNA expression induced by hapten differs from that induced by primary irritant in human skin organ culture system. J Dermatol 25:421-428
38. Nakajima M, Ito N, Nishi K, Okamura Y, Hirota T (1988) Cytochemical localization of blood group substances in human salivary glands using lectin-gold complexes. J Histochem Cytochem 36:337-348
39. Nakayama J, Ota M, Honda T, Katsuyama T (1987) Histochemical demonstration of sugar residues by lectin and immunocytochemical techniques for blood group antigens in human colon. Histochem J 19:454-464
40. O'Donnell JS, McKinnon TA, Crawley JT, Lane DA, Laffan MA (2005) Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis. Blood 106:1988-1991
41. Oriol R (1995) ABO, Hh, Lewis, and secretion serology, genetics and tissue distribution. In Cartron J-P, Ronger P, eds. Blood Cell Biochemistry, vol. 6, Molecular basis of human blood group antigens. New York, Plenum Press, 37-73
42. Pendu JLE, Lambert F, Samuelsson B, Breimer ME, Seitz RC, Urdaniz MP, Suesa N, et al. (1986) Monoclonal antibodies specific for type 3 and type 4 chain-based blood group determinants: relationship to the A1 and A2 subgroups. Glycoconj J 3:255-271
43. Ravn V, Dabelsteen E (2000) Tissue distribution of histo-blood group antigens. APMIS 108:1-28
44. Shima M, Fujimura Y, Nishiyama T, Tsujiuchi T, Narita N, Matsui T, Titani K, et al. (1995) ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sang 68:236-240
45. Sotozono MA, Okada Y, Tsuji T (1994) The Thomsen-Friedenreich antigen-related carbohydrate antigens in human gastric intestinal metaplasia and cancer. J Histochem Cytochem 42:1575-1584
46. Takamiya M, Saigusa K, Aoki Y (2002) Immunohistochemical study of basic fibroblast growth factor and vascular endothelial growth factor expression for age determination of cutaneous wounds. Am J Forensic Med Pathol 23:264-267
47. Terui T, Hirao T, Sato Y, Uesugi T, Honda M, Iguchi M, Matsumura N, et al. (1998) An increased ratio of interleukin-1 receptor antagonist to interleukin-1α in inflammatory skin diseases. Exp Dermatol 7:327-334
48. Zezos P, Papaioannou G, Nikolaidis N, Vasiliadis T, Giouleme O, Evgenidis N (2005) Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation. World J Gastroenterol 11:7639-7645
49. Zhu K, Amin MA, Kim MJ, Katschke KJ Jr, Park CC, Koch AE (2003) A novel function for a glucose analog of blood group H antigen as a mediator of leukocyte-endothelial adhesion via intracellular adhesion molecule 1. J Biol Chem 278:21869-21877